CVS Health Working Capital Trend

CVS -- USA Stock  

Fiscal Quarter End: December 31, 2019  

This module enables investors to look at CVS Health various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Direct Expenses of 132.3 B, Consolidated Income of 4.2 B or Cost of Revenue of 106.2 B, but also many exotic indicators such as Interest Coverage of 7.0765, Long Term Debt to Equity of 0.86 or Calculated Tax Rate of 95.2946. This module is a perfect complement to use when analyzing CVS Health Valuation or Volatility. It can also complement various CVS Health Technical models. Check also analysis of CVS Health Correlation with competitors.

CVS Health Working Capital Marginal Breakdown

Showing smoothed Working Capital of CVS Health Corporation with missing and latest data points interpolated. Working capital measures the difference between [AssetsC] and [LiabilitiesC].
View

7.21 B

          10 Years Trend
Increasing
Slightly volatile
 Working Capital 
      Timeline 

CVS Health Regression Statistics

Arithmetic Mean 3,223,945,455
Geometric Mean 2,997,372,937
Coefficient Of Variation 44.26
Mean Deviation 724,555,372
Median 3,036,000,000
Standard Deviation 1,427,051,069
Range 5,975,000,000
R Value 0.61
R Squared 0.37
Significance 0.048343
Slope 260,550,909

CVS Health Working Capital Over Time

2010  3,036,000,000 
2018  2,732,400,000 
2019  7,209,000,000 

Other Fundumenentals of CVS Health

Search macroaxis.com